Rankings
▼
Calendar
EWTX Q3 2020 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
EWTX
Edgewise Therapeutics, Inc.
$3B
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.18
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$70,000
← FY 2020
All Quarters
Q4 2020 →
